Veterinary Medicines

Duphalyte - Roztwór do wstrzykiwań

Authorised
  • L-histidine hydrochloride
  • Isoleucine
  • Phenylalanine
  • Dexpanthenol
  • Leucine
  • L-lysine hydrochloride
  • Methionine
  • Threonine
  • Tryptophan
  • Valine
  • Potassium chloride
  • Sodium glutamate
  • Glucose
  • Thiamine hydrochloride
  • Pyridoxine hydrochloride
  • Nicotinamide
  • Cyanocobalamin
  • Riboflavin
  • Calcium chloride hexahydrate
  • Magnesium sulfate
  • L-arginine hydrochloride
  • L-CYSTEINE
Download as PDF

Product identification

Medicine name:
Duphalyte - Roztwór do wstrzykiwań
Active substance:
  • L-histidine hydrochloride
  • Isoleucine
  • Phenylalanine
  • Dexpanthenol
  • Leucine
  • L-lysine hydrochloride
  • Methionine
  • Threonine
  • Tryptophan
  • Valine
  • Potassium chloride
  • Sodium glutamate
  • Glucose
  • Thiamine hydrochloride
  • Pyridoxine hydrochloride
  • Nicotinamide
  • Cyanocobalamin
  • Riboflavin
  • Calcium chloride hexahydrate
  • Magnesium sulfate
  • L-arginine hydrochloride
  • L-CYSTEINE
Target species:
  • Cattle
  • Horse
  • Cat
  • Chicken (hen)
  • Pig
  • Dog
Route of administration:
  • Subcutaneous use
  • Intravenous use
  • Intraperitoneal use

Product details

Active substance and strength:
  • L-histidine hydrochloride
    0.01
    milligram(s)
    /
    1.00
    millilitre(s)
  • Isoleucine
    0.01
    milligram(s)
    /
    1.00
    millilitre(s)
  • Phenylalanine
    0.03
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dexpanthenol
    0.05
    milligram(s)
    /
    1.00
    millilitre(s)
  • Leucine
    0.04
    milligram(s)
    /
    1.00
    millilitre(s)
  • L-lysine hydrochloride
    0.03
    milligram(s)
    /
    1.00
    millilitre(s)
  • Methionine
    0.01
    milligram(s)
    /
    1.00
    millilitre(s)
  • Threonine
    0.02
    milligram(s)
    /
    1.00
    millilitre(s)
  • Tryptophan
    0.01
    milligram(s)
    /
    1.00
    millilitre(s)
  • Valine
    0.05
    milligram(s)
    /
    1.00
    millilitre(s)
  • Potassium chloride
    0.02
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium glutamate
    0.04
    milligram(s)
    /
    1.00
    millilitre(s)
  • Glucose
    45.46
    milligram(s)
    /
    1.00
    millilitre(s)
  • Thiamine hydrochloride
    0.10
    milligram(s)
    /
    1.00
    millilitre(s)
  • Pyridoxine hydrochloride
    0.10
    milligram(s)
    /
    1.00
    millilitre(s)
  • Nicotinamide
    1.50
    milligram(s)
    /
    1.00
    millilitre(s)
  • Cyanocobalamin
    0.05
    microgram(s)
    /
    1.00
    millilitre(s)
  • Riboflavin
    0.04
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium chloride hexahydrate
    0.23
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium sulfate
    0.29
    milligram(s)
    /
    1.00
    millilitre(s)
  • L-arginine hydrochloride
    0.03
    milligram(s)
    /
    1.00
    millilitre(s)
  • L-CYSTEINE
    0.01
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
    • Chicken (hen)
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
    • Chicken (hen)
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
  • Intraperitoneal use
    • Cattle
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
    • Chicken (hen)
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB05B
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Polska Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0141
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download